Bristol-Myers Squibb Company
2,4-dihydroxy-nicotinamides as APJ agonists
Last updated:
Abstract:
The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
13 Oct 2016
Issue date:
27 Aug 2019